Indaptus Therapeutics entered into a Standby Equity Purchase Agreement with Yorkville allowing it to sell up to $20 million of common stock over 36 months, while also terminating a previous agreement with Lincoln Park Capital. The agreement includes issuing 305,960 shares to Yorkville and has conditions regarding stock issuance limits and SEC registration.